Price $7.84 |
Market Cap
58.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
30.0
|
P/B
-
|
P/S
1.97
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
12.3
|
Op. Cash Flow
5.4K
|
FCF
0.6
|
|
Op. Margin
16.60%
|
Net Margin
6.40%
|
ROE
-19.00%
|
ROI
94.90%
|
|
ROA
5.20%
|
EPS Growth
358.30%
|
Current Ratio
1.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.60 | - | - | 1.32B | Strong Buy |
| Hologic, Inc. (HOLX) | $47.84 | - | - | 11.78B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.08 | - | - | 87.4M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.09 | - | - | 106.5M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $49.17 | - | - | 1.31B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
